COLL FY 2015 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$171,000

Operating Income

-$27M

Net Income

-$27M

EPS (Diluted)

$-2.01

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$98M

Total Liabilities

$13M

Stockholders' Equity

$85M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$171,000	$0	—
Operating Income	-$27M	-$18M	-52.3%
Net Income	-$27M	-$18M	-52.1%